Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of long-term combination
therapy with alogliptin (Nesina) and thiazolidinediones in patients with type 2 diabetes
mellitus who failed to respond adequately to treatment with thiazolidinediones in addition to
diet therapy and exercise therapy.